Idiopathic pulmonary fibrosis : What primary care physicians need to know
Copyright © 2018 Cleveland Clinic..
Idiopathic pulmonary fibrosis (IPF) is a specific type of fibrosing interstitial pneumonia of unknown cause. It is usually chronic and progressive, tends to affect mainly adults over age 60, has a predilection for men, and is often fatal. The condition is still underappreciated by pulmonologists and primary care physicians. This article attempts to close that information gap by reviewing the natural course of IPF and presenting an algorithmic approach to diagnosis and treatment based on evidence-based international guidelines. New treatment options are briefly discussed, to raise awareness of new medications that target pulmonary fibrosis.
| Errataetall: |
CommentIn: Cleve Clin J Med. 2018 May;85(5):387-389. - PMID 29733780 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
|---|---|
| Enthalten in: |
Cleveland Clinic journal of medicine - 85(2018), 5 vom: 20. Mai, Seite 377-386 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tolle, Leslie B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 20.11.2018 Date Revised 20.11.2018 published: Print CommentIn: Cleve Clin J Med. 2018 May;85(5):387-389. - PMID 29733780 Citation Status MEDLINE |
|---|
| doi: |
10.3949/ccjm.85a.17018 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM283808349 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM283808349 | ||
| 003 | DE-627 | ||
| 005 | 20231225041746.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3949/ccjm.85a.17018 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0946.xml |
| 035 | |a (DE-627)NLM283808349 | ||
| 035 | |a (NLM)29733782 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tolle, Leslie B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Idiopathic pulmonary fibrosis |b What primary care physicians need to know |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.11.2018 | ||
| 500 | |a Date Revised 20.11.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Cleve Clin J Med. 2018 May;85(5):387-389. - PMID 29733780 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2018 Cleveland Clinic. | ||
| 520 | |a Idiopathic pulmonary fibrosis (IPF) is a specific type of fibrosing interstitial pneumonia of unknown cause. It is usually chronic and progressive, tends to affect mainly adults over age 60, has a predilection for men, and is often fatal. The condition is still underappreciated by pulmonologists and primary care physicians. This article attempts to close that information gap by reviewing the natural course of IPF and presenting an algorithmic approach to diagnosis and treatment based on evidence-based international guidelines. New treatment options are briefly discussed, to raise awareness of new medications that target pulmonary fibrosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Southern, Brian D |e verfasserin |4 aut | |
| 700 | 1 | |a Culver, Daniel A |e verfasserin |4 aut | |
| 700 | 1 | |a Horowitz, Jeffrey C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cleveland Clinic journal of medicine |d 1996 |g 85(2018), 5 vom: 20. Mai, Seite 377-386 |w (DE-627)NLM012620769 |x 1939-2869 |7 nnns |
| 773 | 1 | 8 | |g volume:85 |g year:2018 |g number:5 |g day:20 |g month:05 |g pages:377-386 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3949/ccjm.85a.17018 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 85 |j 2018 |e 5 |b 20 |c 05 |h 377-386 | ||